WebApr 10, 2024 · Payment of $1.7 million permits the start of activities to manufacture and sell the MyoPro® in China. Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces receipt of the final … WebApr 10, 2024 · Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or …
Myomo Receives Technology License Fee Payment from China …
WebMar 16, 2024 · MENLO PARK, Calif., March 16, 2024 /PRNewswire/ -- MyOme, Inc., a clinical whole genome platform analysis company and a leader in the development of polygenic … WebMyOme is a company developing a whole genome analysis platform to help people understand their risk for inherited diseases. It offers whole genome sequencing, single … 颯 ブランチ
MyOme - Overview, News & Competitors ZoomInfo.com
WebOct 27, 2024 · MyOme, Inc Oct 27, 2024, 18:00 ET. Share this article. Share this article. Addition of a cross-ancestry polygenic risk score to the standard of care clinical risk predictor tool improved breast ... WebFeb 28, 2024 · About MYOME, INC. Myome, Inc. is a provider established in San Carlos, California operating as a Clinical Medical Laboratory. The NPI number of this provider is 1336895366 and was assigned on February 2024. The practitioner's primary taxonomy code is 291U00000X. tarif 783